Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP-1 weight-loss drugs in high demand.

Yahoo Finance Health Reporter Anjalee Khemlani joins Market Domination Overtime to break down Eli Lilly's investment into the new plant and what it means for the company moving forward.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime.

This post was written by Nicholas Jacobino